Eupraxia Pharmaceuticals (EPRX) Ownership - Who owns Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EPRX showed earnings on May 06, 2025. You can read more about the earnings report here.